ESR2 and breast carcinoma: Treatment of MDA-MB-231 and ERβ-overexpressing SK-BR-3 breast cancer cells with the Erβ-specific agonist DPN caused autophagy through CLDN6-mediated upregulation of the key mediator of autophagy beclin-1 (Figure 1).